Digital Vasculature Image Supports Access Procedures
By HospiMedica International staff writers Posted on 23 Aug 2015 |
Image: The VeinViewer Vision2 projected vein image (Photo courtesy of Christie Medical Holdings).
A novel device uses near-infrared (NIR) light to create a digital image of patient vasculature that assists clinicians in finding the optimal venipuncture site.
The VeinViewer Vision2 works by projecting NIR light onto the skin, which is absorbed by the blood while reflected by surrounding tissue. The information is captured, processed and projected digitally directly onto the surface of the skin, providing a real time accurate image of the patient’s blood pattern. Patented active vascular imaging navigation (AVIN), allows clinicians to see blood patterns up to 15 mm in depth, including peripheral veins, bifurcations, and valves, as well as assess the refill/flushing of veins.
The system uses Digital Full Field (Df2) technology throughout the process. Pre-access, the VeinViewer Vision2 helps avoid problematic valves and bifurcations and find the optimal access point and vessel target that is sufficient for the length of the catheter. During-access, the real-time Df² imaging allows immediate adjustment to navigate curves, visualize a rolling vein, and observe the flush of IV fluids to determine if the catheter is flowing properly. Post-access, VeinViewer can help assess the patency of the vessel and detect a hematoma from an accidental puncture as it forms.
Customization options include changing the color of the projected image, invert or resize the image, enhance the image using a fine detail mode, increase or decrease the image brightness, or take and store a file of the image. The customization process helps clinicians to choose which mode provides the best image for their needs, as well as which mode provides the best image of a specific patient’s vasculature. The VeinViewer Vision2 is a product of Christie Medical Holdings (Memphis, TN, USA).
“Only VeinViewer can provide pre-, during, and post-access benefits throughout the entire vascular access procedure,” said George Pinho, president of Christie Medical Holdings. “It is also the only device of its kind that has been shown through clinical studies to increase both first-stick success and patient satisfaction by up to 100%, while reducing medically unnecessary PICC lines by over 30%.”
Related Links:
Christie Medical Holdings
The VeinViewer Vision2 works by projecting NIR light onto the skin, which is absorbed by the blood while reflected by surrounding tissue. The information is captured, processed and projected digitally directly onto the surface of the skin, providing a real time accurate image of the patient’s blood pattern. Patented active vascular imaging navigation (AVIN), allows clinicians to see blood patterns up to 15 mm in depth, including peripheral veins, bifurcations, and valves, as well as assess the refill/flushing of veins.
The system uses Digital Full Field (Df2) technology throughout the process. Pre-access, the VeinViewer Vision2 helps avoid problematic valves and bifurcations and find the optimal access point and vessel target that is sufficient for the length of the catheter. During-access, the real-time Df² imaging allows immediate adjustment to navigate curves, visualize a rolling vein, and observe the flush of IV fluids to determine if the catheter is flowing properly. Post-access, VeinViewer can help assess the patency of the vessel and detect a hematoma from an accidental puncture as it forms.
Customization options include changing the color of the projected image, invert or resize the image, enhance the image using a fine detail mode, increase or decrease the image brightness, or take and store a file of the image. The customization process helps clinicians to choose which mode provides the best image for their needs, as well as which mode provides the best image of a specific patient’s vasculature. The VeinViewer Vision2 is a product of Christie Medical Holdings (Memphis, TN, USA).
“Only VeinViewer can provide pre-, during, and post-access benefits throughout the entire vascular access procedure,” said George Pinho, president of Christie Medical Holdings. “It is also the only device of its kind that has been shown through clinical studies to increase both first-stick success and patient satisfaction by up to 100%, while reducing medically unnecessary PICC lines by over 30%.”
Related Links:
Christie Medical Holdings
Latest Critical Care News
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events